ArticleJHEP reports : innovation in hepatology2023

Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid.

Jessica T Hochberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.